Phase II study of temozolomide (TMZ) and pegylated interferon alpha-2b (PGI) in the treatment of advanced melanoma Meeting Abstract
| Authors: | Krown, S. E.; Hwu, W. J.; Menell, J. H.; Panageas, K. S.; Lamb, L. A.; Aird, S.; Williams, L. J.; Chapman, P. B.; Livingston, P. O.; Wolchok, J. D. |
| Abstract Title: | Phase II study of temozolomide (TMZ) and pegylated interferon alpha-2b (PGI) in the treatment of advanced melanoma |
| Meeting Title: | 40th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 22 |
| Issue: | 14 Suppl. |
| Meeting Dates: | 2004 Jun 5-8 |
| Meeting Location: | New Orleans, LA |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2004-07-15 |
| Start Page: | 718S |
| Language: | English |
| ACCESSION: | WOS:000223512402849 |
| PROVIDER: | wos |
| DOI: | 10.1200/jco.2004.22.90140.7533 |
| Notes: | Meeting Abstract: 7533 -- 40th Annual Meeting of the American-Society-of-Clinical-Oncology -- JUN 05-08, 2004 -- New Orleans, LA -- S -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
